FindTrial
Sign In

To study the risk and molecular mechanism of metabolic syndrome in PCOS assisted progeny based on birth cohort

To study the risk and molecular mechanism of metabolic syndrome in PCOS assisted progeny based on birth cohort

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053409
Enrollment
Unknown
Registered
2021-11-20
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovarian syndrome

Interventions

Group PCOS:NO
Group without PCOS:NO

Sponsors

Fujian Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. PCOS patients diagnosed according to the 2018 Chinese Guidelines for the Diagnosis and Treatment of Polycystic ovary Syndrome; 2. Aged <= 35 years; 3. All IVF protocols were antagonist protocols.

Exclusion criteria

Exclusion criteria: Other endocrine diseases, such as Cushing's syndrome, thyroid dysfunction, hyperprolactinemia, etc.

Design outcomes

Primary

MeasureTime frame
fasting blood-glucose;lipid metabolism;—

Secondary

MeasureTime frame
Offspring birth weight;Offspring birth height;Offspring head circumference;Neonatal complications;—

Countries

China

Contacts

Public ContactLiu Guanghua

Fujian Maternal and Child Health Hospital

fjfy_xrcx@163.com+86 591 87279505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026